John B. Mulliken - Concepedia

Author

John B. Mulliken

Also Known As

J B Mulliken, J MULLIKENC, J Mulliken, J. B. Mulliken, J. Mulliken, J.B Mulliken, J.B. Mulliken, JOHN B MULLIKEN, JOHN B. MULLIKEN, John B Mulliken

683

Publications

55.5K

Citations

126

H-Index

272

Concepts

All Affiliations

Boston Children's Hospital Harvard University Brigham and Women's Hospital Boston Children's Museum

About

John B. Mulliken is an author at Boston Children's Hospital specializing in medicine, pathology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	22	27	2.8K
2	Education	3	3	51
3	Arts	2	2	130
4	Engineering	1	1	213
5	Humanities	1	1	14

John B. Mulliken

427

Publications

49.1K

Citations

116

H-Index

Page 1

	Year	Citations
Hemangiomas and Vascular Malformations in Infants and Children John B. Mulliken, Julie Glowacki Plastic & Reconstructive Surgery	1982	3.3K
Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia Stefan Mundlos, F Otto, C Mundlos, Cell Genetic DisorderGeneticsCraniofacial DevelopmentDisease Gene IdentificationMedicine	1997	1.5K
Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy R. Alan B. Ezekowitz, John B. Mulliken, Judah Folkman New England Journal of Medicine	1992	1.1K
Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 Miikka Vikkula, Laurence M. Boon, Kermit L. Carraway, Cell Activating MutationAngiogenesisSignal TransductionMolecular PhysiologySignaling Pathway	1996	803
Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 Mutations Iiro Eerola, Laurence M. Boon, John B. Mulliken, The American Journal of Human Genetics Capillary Malformation–arteriovenous MalformationRasa1 MutationsGenetic DisorderVascular MalformationPathology	2003	742
A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis Ethylin Wang Jabs, Ulrich Müller, Xiang Li, Cell SclerostinDevelopmental BiologyGenetic DisorderGeneticsHuman Msx2 Gene	1993	678
Donor-Site Morbidity after Harvesting Rib and Iliac Bone Simon W. S. Laurie, Leonard B. Kaban, John B. Mulliken, Plastic & Reconstructive Surgery	1984	653
Cellular markers that distinguish the phases of hemangioma during infancy and childhood. Kenkichi Takahashi, John B. Mulliken, Harry P. Kozakewich, Journal of Clinical Investigation ImmunologyVascular MalformationPathologyCellular MarkersTumor Biology	1994	649
Congenital vascular lesions: Clinical application of a new classification Mary Collins Finn, Julie Glowacki, John B. Mulliken Journal of Pediatric Surgery Congenital Vascular LesionsPediatricsVascular SurgeryVascular MalformationCongenital Heart Anomaly	1983	598
Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CA Valerie L. Luks, Nolan Kamitaki, Matthew P. Vivero, The Journal of Pediatrics Developmental AnomalyDevelopmental BiologySomatic MutationsSomatic VariantGenetic Disorder	2015	565

Page 1